Axonics (AXNX) said late Wednesday that the jury has returned a unanimous verdict that the company did not infringe any of the three patents in the lawsuit brought by Medtronic in the US District Court for the Central District of California.

"A jury of our peers recognized that Axonics' proprietary tined lead design and temperature sensor technology is differentiated from our competitor's intellectual property," Chief Executive Raymond Cohen said.

Shares of Axonics rose more than 2% in aftermarket hours on Wednesday.

Price: 70.50, Change: +1.78, Percent Change: +2.59